Previous 10 | Next 10 |
Dogecoin (CRYPTO: DOGE) , in many ways, is at the epicenter of the cryptocurrency craze. Its price appreciated by a staggering 12,000% during just the first five months of 2021. The probability that this star of the cryptocurrency world will keep churning higher, however, appears to...
Shares of Verastem Inc. (NASDAQ:VSTM) traded at a new 52-week high today of $4.26. This new high was reached on below average trading volume as 2.1 million shares traded hands, while the average 30-day volume is approximately 3.3 million shares. There is potential upside of 86.9% for sha...
Shares of Verastem Inc. (NASDAQ:VSTM) traded at a new 52-week high today of $4.10. Approximately 2.1 million shares have changed hands today, as compared to an average 30-day volume of 2 million shares. Verastem Inc. share prices have moved between a 52-week high of $4.10 and a 52-week l...
Shares of Verastem Inc. (NASDAQ:VSTM) traded today at $4.06, eclipsing its 52-week high. Approximately 2.1 million shares have changed hands today, as compared to an average 30-day volume of 2 million shares. Verastem Inc. share prices have moved between a 52-week high of $4.06 and a 52-...
Shares of Verastem Inc. (NASDAQ:VSTM) traded today at $4.04, eclipsing its 52-week high. Approximately 2.1 million shares have changed hands today, as compared to an average 30-day volume of 2 million shares. Potential upside of 87.6% exists for Verastem Inc., based on a current level of...
Verastem ([[VSTM]] +3.0%) has submitted the corporate presentation which will be made on June 01, at 4:00 p.m. ET at Jefferies Virtual Healthcare Conference.This week, the company announced the Breakthrough Therapy designation it received from the FDA for the VS-6766/ defactinib combo in...
3 Penny Stock Gainers You Might Have Missed Yesterday Finding the best penny stocks to buy can be challenging. However, investors will often use the biggest gainers from the previous day, for some penny stocks watchlist inspiration. This is a great strategy, but it’s worth no...
Shares of the small-cap cancer company Verastem (NASDAQ: VSTM) are up by a healthy 26% as of 3:22 p.m. EDT Monday afternoon. The biotech's shares are perking up today in response to the decision by the Food and Drug Administration (FDA) to grant the coveted Breakthrough Therapy ...
Gainers: Scopus BioPharma (SCPS) +97%.MMA Capital (MMAC) +58%.Aptorum (APM) +37%.Creative Realities (CREX) +33%.Obalon Therapeutics (OBLN) +30%.Regional Health Properties (RHE) +24%.Taiwan Liposome (TLC) +21%.Virgin Galactic (SPCE) +19%.Verastem (VSTM) +18%.Veritiv (VRTV) +17%.Loser...
Verastem ([[VSTM]] +15.7%) has risen sharply during intraday trading after the company announced the FDA’s Breakthrough Therapy designation it received for the combination of VS-6766 and defactinib for the treatment of all patients with recurrent low-grade serous ovarian canc...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...